NEW YORK, July 11, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of Florida on behalf of all persons or entities who purchased or otherwise acquired MEDNAX, Inc. (NYSE:MD) securities between February 2, 2016 and July 27, 2017 (the “Class Period”). Investors have until September 10, 2018 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
The complaint alleges that, on July 28, 2017, Mednax announced, during its second quarter earnings call with investors and analysts, that the Company failed to complete any acquisitions of anesthesiologist practices during the quarter. Significantly, the Company also disclosed that any future anesthesiologist acquisitions were unlikely, which Mednax attributed to the “challenging” payor mix combined with “continued . . . growth in compensation expense for nurse anesthetists.” On this news, the price of Mednax stock declined from $56.49 per share on July 27, 2017, to close at $47.73 per share on July 28, 2017, a drop of 15.5%.
If you purchased Mednax securities during the Class Period or continue to hold shares purchased prior to the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at firstname.lastname@example.org, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning the MEDNAX, Inc. (NYSE:MD) lawsuit, please go to https://bespc.com/mednax/. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.